Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
NewsWire
|
Diversicare Healthcare Services Inc., a provider of long-term care services, has reported that net loss available to common shareholders for the first quarter ended March 31, 2013 was $1.05 million, or $0.18 loss per share, compared to a net loss available to common shareholders of $1.54 million, or $0.27 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Trimel Pharmaceuticals Corporation, a specialty pharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $8.43 million, or $0.09 loss per share, compared to a net loss of $6.37 million or $0.08 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Millennium HealthCare Inc., a healthcare support and service company, has announced that its Medical Device subsidiary signed an exclusive distribution agreement with Heart Smart Inc., a distributor of diagnostic equipment and technology, for the VasoScan assessment device.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Antares Pharma, Inc., a provider of self-administered parenteral pharmaceutical products and topical gel-based medicines, has reported that net loss for the first quarter ended March 31, 2013 was $3.41 million, or $0.03 loss per share, compared to a net loss of $74,000, or $0 per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Biosense Webster, Inc., a developer of diagnosis and treatment of cardiac arrhythmias, has enrolled the first patient in the reMARQable clinical study.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Extendicare Inc., a provider of post-acute and long-term senior care services, has announced the retirement of Doug Harris, senior vice president and CFO, effective July 5, 2013.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
VIVUS, Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $53.58 million, or $0.53 loss per share, compared to a net loss of $18.78 million or $0.20 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Nephros, Inc., a medical device company, has reported that net loss for the first quarter ended March 31, 2013 was $1.24 million, or $0.10 loss per share, compared to a net loss of $557,000 or $0.05 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
TherapeuticsMD, Inc., a women's healthcare company, has reported that net loss for the first quarter ended March 31, 2013 was $6.37 million, or $0.06 loss per share, compared to a net loss of $13.29 million or $0.16 loss per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
22 May 2013 |
|
NewsWire
|
Depomed, Inc., a specialty pharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $5.48 million, or $0.10 loss per share, compared to a net loss of $8.80 million, or $0.16 loss per share, for the same quarter ended March 31, 2012. For 2013, the company expects total revenues to be in the range of $125 million to $135 million.
Published By MarketLine
|
22 May 2013 |
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.